Hillstream BioPharma (HILS) Selects OncoBay Clinical to Advance Development of HSB-1216 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Hillstream BioPharma Selects OncoBay Clinical to Advance Clinical and Regulatory Development for its Lead Drug Candidate HSB-1216, an Anti-Cancer Mechanism streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BRIDGEWATER, NJ / ACCESSWIRE / April 12, 2023 / A surge in oncology drug development, coupled with increased patient access and early diagnosis, has resulted in a massive increase in global spending on
Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Rating) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 116,100 shares, an increase of 25.1% from the February 28th total of 92,800 shares. Based on an average trading volume of 3,020,000 shares, the […]